Related Experiment Video

Updated: Apr 29, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Overcoming toxicity and side-effects of lipid-lowering therapies

Michael J Wilkinson1, Luke J Laffin1, Michael H Davidson1

  • 1University of Chicago, Department of Medicine, Chicago, IL, USA.

Best Practice & Research. Clinical Endocrinology & Metabolism
|May 21, 2014
PubMed

Insights

Managing statin therapy side effects is crucial for cardiovascular disease prevention. Clinicians can minimize adverse events by assessing risks and tailoring treatment, ensuring patient safety and adherence to lipid-lowering drugs.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Lowering serum lipids is fundamental for cardiovascular disease (CVD) treatment and prevention.
  • New guidelines emphasize high-efficacy statins over LDL-c goals for high-risk patients.
  • Effective management of statin therapy side effects is essential for clinical practice.

Purpose of the Study:

  • To outline strategies for managing statin therapy side effects.
  • To provide clinicians with an approach for addressing adverse events associated with lipid-lowering drugs.
  • To emphasize individualized treatment plans for cholesterol management.

Main Methods:

  • Review of current literature on statin-associated adverse effects.
  • Analysis of clinical guidelines and management strategies for statin toxicity.
  • Discussion of risk factor assessment and treatment modification techniques.

Main Results:

  • Statins can cause myopathy, transaminase elevations, and increased diabetes risk.
  • Statin side effects may be minimized through careful risk assessment.
  • Strategies include dose adjustment, intermittent dosing, switching statins, or adding non-statin agents.

Conclusions:

  • Individualized therapy is key to managing cholesterol and mitigating adverse drug effects.
  • Clinicians should tailor treatment based on patient risk factors and cholesterol goals.
  • Available management strategies and algorithms can guide the safe use of lipid-lowering drugs.

Keywords:
atherosclerosiscardiovascular diseasesdrug toxicityhydroxymethylglutaryl-CoA reductase inhibitorshypercholesterolemialipoproteins

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.7K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
295